Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?

Recent advances in the treatment of early breast cancer have improved clinical outcomes and prolonged survival, especially in women with endocrine-responsive disease. However, cancer therapies including cytotoxic chemotherapy, ovarian suppression, and aromatase inhibitors can drastically reduce circ...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gnant, Michael, Blaha, Peter, Dubsky, Peter, Exner, Ruth, Fitzal, Florian, Sporn, Emanuel, Panhofer, Peter, Borgo, Andrea Dal, Bigenzahn, Sinda, Steger, Guenther, Jakesz, Raimund
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2009
Gaiak:
Reviews
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3126000/
https://ncbi.nlm.nih.gov/pubmed/21789117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834009344594
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak